Sociedad Química y Minera de Chile (SQM) investor relations material

Financial performance highlights

• Last twelve months revenue reached US$6.7 billion, with adjusted EBITDA of US$3.1 billion and a 46% margin as of June 30, 2026.

• Q2 2026 revenue was US$2,468 million, up 40% quarter-on-quarter and 12% year-on-year.

• Adjusted EBITDA for Q2 2026 was US$1,318 million, with a 53% margin, up 57% quarter-on-quarter and 82% year-on-year.

• Net income for Q2 2026 was US$660 million, up 81% quarter-on-quarter and 403% year-on-year.

• Net financial debt to adjusted EBITDA ratio stood at 0.3x as of June 30, 2026.

Business line performance

• Lithium and derivatives contributed 64% of revenues and 71% of gross profit, with strong sales volumes (+59%) and higher average prices (+152%).

• Iodine and derivatives accounted for 16% of revenues, with higher sales volumes (+9%) and record prices (+3%).

• Specialty Plant Nutrition (SPN) made up 16% of revenues, with sales volumes up 14% and prices up 8%.

• Potassium and industrial chemicals contributed 2% and 1% of revenues, respectively, with stable or recovering demand.

Market and operational outlook

• Global lithium market demand expected to exceed 2.1 million MT in 2026, with tight supply-demand balance.

• Estimated lithium production for 2026 is 280-290 ktons LCE, with capacity expected to surpass 300 ktons by 2027.

• Iodine market share is ~37%, with demand growth of 3-4% expected in 2026, driven by x-ray contrast media.

• SPN market share is ~39%, with 2026 sales volume growth projected at close to 10% due to Middle East conflict.

• Industrial chemicals market share is ~13%, with stable outlook for 2026.